Tag: AML

How Blood Cancer Cells Rewire to Evade Drug Treatment
Oncotarget

How Blood Cancer Cells Rewire to Evade Drug Treatment

October 23, 2024
“[...] drugs that target individual signalling pathways in AML often fail to stop proliferation malignant growth, due to the wide variety, redundancy and cross talk between multiple pathways regulating and… read more
Dr. Michael Andreeff
Oncotarget

Testimonial: Dr. Michael Andreeff

November 5, 2021
Below is a transcript of the testimonial by Dr. Michael Andreeff, from the University of Texas MD Anderson Cancer Center, about his experience publishing the paper, “Tumor Trp53 status and genotype affect the bone marrow… read more